Gastrointestinal and hepatic manifestations of COVID-19 infection: Lessons for practitioners

Table 11 Interim infection prevention and control guidelines by Centers for Disease Control and Prevention[172]

Interim Infection Prevention and Control guidelines by CDC
Encourage and promote Telehealth visits over in-person visits whenever possible.
COVID-19 symptom screening for everyone entering a healthcare facility.
Limiting entry points to a healthcare facility, ensuring effective screening for all.
Encourage hand hygiene and source control measures for everyone, especially HCWs.
Encourage physical distancing and limiting the number of visitors and personnel at any given time.
Implementing use of PPEs (e.g. N95/PAPR) for HCWs in areas with moderate to substantial community spread.
To mitigate spread from asymptomatic carriers; depending on the availability, a targeted SARS-CoV-2 testing for all patients can be considered.
To reduce exposures for HCWs the use of Engineering controls should be optimized.

CDC: Centers for Disease Control and Prevention; PPE: Personal protective equipment; HCWs: Healthcare workers; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2.